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1. Introduction 
Microemulsion techniques are capable of delivering organic and inorganic nano-sized particles 
with minimal agglomeration because the reaction occurs in nano-sized domains. However, 
microemulsion techniques present several disadvantages, including the use of a large amount 
of oil and surfactant and low yield. Nevertheless, microemulsion techniques are an alternative 
method for synthesising several types of inorganic and organic nano-sized particles1, 2, 3. 
The use of microemulsions as vehicles for pharmaceutical preparations and drug release 
systems has aroused significant interest due to their potential advantages4, which can be 
attributed to their ability to improve the solubility of hydrophilic and lipophilic substances 
and their capacity to increase the stability and absorption of drugs, allowing greater 
bioavailability5. 
Furthermore, microemulsions can provide sustained drug release by compartmentalising 
active substances within structures organised by surfactants, water and oil, allowing the 
slow and continuous release of drugs over a long period of time6. 
Microemulsion is a suitable technique for obtaining nanometre-sized inorganic particles 
with minimal agglomeration7. Microemulsion is the thermodynamically stable, 
transparent, isotropic dispersion of two immiscible liquids such as water and oil, which 
are stabilised by surfactant molecules at the water/oil interface. In water-in-oil 
microemulsions, nano-sized water droplets are dispersed in the continuous hydrocarbon 
phase and are surrounded by a monolayer of surfactant molecules7. The diameter of 
aqueous droplets is usually 5–20 nm1,8. The aqueous droplets act as a microreactor or 
nanoreactor, and reactions occur when droplets containing suitable reactants collide with 
each other. First, precursor particles of hydroxide or oxalate are formed in a 
microemulsion system. After drying and calcination of the precursor powder at an 
appropriate temperature, the desired oxide system is obtained. 
A number of biological barriers are present between the application site and the place where 
substances exert their pharmacological effect; thus, many pharmacologically active substances 
fail to achieve the appropriate concentration in the target tissue, and normal tissues of the 
body are exposed to the effects of potentially toxic substances. The mucosal immune system is 
a biological barrier that allows the passage of substances under certain conditions. 
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Microemulsions may interact with the stratum corneum and disorganise the lipid bilayer due 
to the presence of surfactants. Thus, these lipids pass as a fluid in a disorderly fashion, 
increasing the permeability of skin. As a result, the penetration of substances is facile. The 
control of drug release by microemulsions is an important advantage when the active 
compound seeks specific targets and therapeutic action must be extended. 
The mucosal barrier control is important for immunomodulatory effects. The 
gastrointestinal and respiratory tract are the most important sites of infection and can act as 
open windows that microorganisms can use for the entrance, invasion and colonisation of 
tissue9. Mucosal surfaces represent an important physical-biological barrier between internal 
and external millieu10. During feeding and respiration, the body comes into contact with 
allergens, harmful substances, and opportunistic and pathogenic microorganisms. 
Notwithstanding, the body-environment equilibrium is almost perfect, and the state of 
illness is exceptional.  
Intestinal mucosa is colonised by numerous bacteria derived from more than 500 different 
species11. Despite high bacterial colonisation and frequent allergen contact, acute 
inflammatory and allergic reactions are rarely observed in the mucosa12.  
Gastrointestinal associated lymphoid tissue (GALT), which is composed of discrete 
inductive and effector sites, is able to discriminate between harmful and harmless antigens 
while maintaining homeostasis.  
Intestinal epithelial cells are the major producers of multiple peptides and proteins with 
antimicrobial activity in the intestine, which are key effector molecules of innate immunity13. 
The differential expression of diverse antimicrobial proteins in the gastrointestinal tract 
suggests that these proteins have distinct functional niches in mucosal innate defence, 
allowing the pharmacological exploitation of their antimicrobial properties14. 
2. Microemulsion  
In 1943,15 Hoar and Schulman described water-in-oil microemulsions, which they referred to 
as transparent water-in-oil dispersions. Subsequently, these systems have been investigated 
by others authors,16 who calculated the size of droplets found in microemulsions.  
Microemulsion is a suitable technique for obtaining nanometre-sized inorganic particles with 
minimal agglomeration29. Oxide and carbonate nanoparticles have been successfully 
synthesised by microemulsion techniques17, 18, 19, 20. A microemulsion is a thermodynamically 
stable, transparent, isotropic dispersion of two immiscible liquids (such as water and oil) that 
are stabilised by surfactant molecules at the water/oil interface. In water-in-oil 
microemulsions, nano-sized water droplets are dispersed in the continuous hydrocarbon 
phase and are surrounded by a monolayer of surfactant molecules21.  
Microemulsions improve therapeutic efficacy, reduce the volume of the drug delivery 
vehicle, mimimise toxic side effects16,22 and improve immunological response5,23,24. In 
addition to these advantages, microemulsions are easy to administer and offer several 
benefits for oral administration. Namely, microemulsions are ideal for the oral and nasal 
delivery of drugs and vaccines25,26,27. Microemulsion techniques are capable of delivering 
inorganic and organic nano-sized particles with minimal agglomeration because the reaction 
occurs in nano-sized domains. 
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However, the major disadvantage of using microemulsion formulations as vehicles for drug 
delivery systems is the high concentration of surfactant and cosurfactants required to create 
these formulations. In microemulsion formulations used for technological applications in oil 
recovery, nanoparticles are composed of incompatible surfactants, cosurfactants, and oils 
that are compatible with human physiology and are non-irritating. Phospholipids, 
particularly lecithin, are nontoxic alternative emulsifiers that can be biocompatible22. 
Biocompatible surfactants and cosurfactants used in pharmaceutical microemulsions are 
important technological challenges for the development of adequate delivery systems that 
can be used in pharceutical formulations and vaccines for treating diseases and improving 
the immune system. 
3. The mucosal immune system  
In general, mucosal tissues are a specialised immune network composed of inductive and 
effector sites. The latter include lamina propria mucosae, the stroma of exocrine glands and 
surface epithelia, whereas inductive sites comprise mucosa-associated lymphoid tissue 
(MALT) and local and regional draining lymph nodes. The histological architecture of 
MALT is similar to the structure of the lymph nodes; however, MALT lacks afferent 
lymphatics. Antigens are captured and processed directly from the mucosal luminal side 
through specialised follicle-associated epithelium (FAE) containing microfold or membrane 
(M) cells. These cells deliver antigens to MALT antigen presenting cells (APCs), which are 
able to stimulate naive B and T cells11. 
Intestinal mucosa is one of the primary tissues that comprise the mucosal immune system 
and possess the highly elaborate architecture of the intestinal system. Intestinal mucosa is 
constantly challenged with the considerable task of allowing the exchange of nutrients, ions 
and liquids across the intestinal epithelium in the presence of an enormous density of 
potentially harmful luminal antigens and microbes27.  
Intestinal mucosa constitutes a barrier equipped with local defence mechanisms against 
invading pathogens; however, the mucosa must be selectively permeable to allow the 
uptake of nutrients. This dual function becomes even more challenging when we consider 
that the intestinal lamina propria contains a large number of immune cells with potent 
effector functions26. The unique architecture of the gastrointestinal tract facilitates both of 
these functions. In particular, the gastrointestinal tract possesses multiple levels and an 
immense overall surface area, allowing maximal nutrient absorption while housing the 
largest number of immune cells in the body27. 
The recognition of invading microorganisms is paramount to the survival of the host, and 
the innate immune system has evolved as the first line of defence in the immune response. 
At the mucosal surface, the host physically interacts with a nonsterile environment, and the 
ability to detect and contain invading pathogens is regularly tested27.28.  
Gastro-intestinal associated lymphoid tissue (GALT), which is composed of discrete 
inductive and effector sites, is able to discriminate between harmful and harmless antigens 
while maintaining homeostasis. Inductive sites are organised into specialised aggregations 
of lymphoid follicles called Peyer's Patches (PP), while effector sites are more diffusely 
dispersed28,29. 
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The separation of these sites limits and controls immune responses. The human 
gastrointestinal tract is colonised by an abundance of bacteria, which are in constant 
interaction with the epithelial lining, leading to an intricate balance between tolerance and 
immunological response. Ample evidence suggests that the abundant presence of bacteria 
plays a role in the maintenance of human health and the induction of chronic inflammatory 
diseases of the gastrointestinal tract30. 
4. Defence of innate and adaptive immunity against infections 
The mucosal barrier is formed by highly adapted epithelial cells, which are interconnected 
with tight junctions and are covered with mucus and bactericidal peptides. As a result, only 
a small number of bacteria are allowed to penetrate the intestinal epithelium. Primary 
defects in the barrier function can trigger intestinal inflammation13, 31. Mucosal surfaces have 
an efficient anti-infective protection system, which consists of many nonspecific mechanisms 
such as peristaltic movements and the transportion of mucus-fimbri, mucosal enzymes and 
antimicrobicidal proteins.  
The mucosa surface presents intestinal epithelial cells, especially paneth cells. Paneth cells 
are the major producers of multiple peptides and proteins with antimicrobial activity in 
the intestine, which are key effector molecules of innate immunity. The most abundant 
and diverse antimicrobial proteins are the defensins, which are highly microbicidal in 
vitro and are likely important in vivo. However, the physiological functions of defensins 
remain incompletely understood. Paneth cells also produce cathelicidin, which 
contributes to the mucosal defence against epithelial-adherent bacterial pathogens, helps 
to set a threshold for productive infection, and is expressed constitutively by neutrophils, 
mast cells and differentiated epithelial cells in the colon and stomach but not the small 
intestine32.  
In contrast, adaptive mechanisms are represented mainly by the mucosal immune system 
(MALT, mucosal associated lymphoid tissue). This system consists of immuno-competent 
cells that infiltrate the mucosae, nodules that form lymphoid structures such as Peyer’s 
plates and its equivalent in bronchial mucosae, and regional lymph nodes such as the 
mesenterics32.  
Under normal conditions, human gut mucosa is infiltrated by a large number of 
mononuclear cells due to the continuous stimulation of luminal antigens33. Approximately 
70% of all lymphocytes in the human body are concentrated in the intestinal intra-epithelial 
and subepithelial layers, and the largest pool of tissue macrophages is located in the 
intestinal wall30.  
Mucosal tissue possesses the largest activated B-cell system of the body and contains 80–
90% of all immunoglobulin (Ig)-producing cells. The major product of these lymphocytes 
is secretory (S) IgA (mainly dimers) with associated J chain18. Polimeric IgA contains a 
binding site for polymeric Ig receptor (pIgR) or secretory component (SC), which is 
required for their active external transport through secretory epithelia. When produced by 
local lymphocytes, the pIgR/SC binding site depends on the covalent incorporation of the 
J chain into the quaternary structure of the polymer. This important differentiation 
appears to be sufficient functional justification for the expression of the J chain by most B-
cells terminating at IgD- or IgG-producing secretory effector sites. These cells likely 
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represent a spin-off from sequential downstream CH switching for subsequent pIgA 
expression, apparently reflecting an effector B-cell clone maturational stage that is 
compatible with homing to these sites11. 
The differential expression of diverse antimicrobial proteins in the gastrointestinal tract 
suggests that they occupy distinct functional niches in mucosal innate defence, allowing the 
pharmacological exploitation of antimicrobial properties associated with active substances 
in microemulsions, which can modulate the mucosal immunological system. 
5. Mucosal immune system and microemulsion  
Over the past several decades, microemulsions have been used in various pharmaceutical 
technologies. For instance, the storage, stability, dosage, viability, side effects, controlled 
release, biological response and homogenous distribution of drugs in microemulsions have 
been explored for their potential use as drug or vaccine delivery systems 23,24. 
Immunisation strategies have largely focused on the use of microemulsions. However, the 
efficiency and/or cost of vaccines must also be improved. In the literature, the theoretical 
basis of current research is to rationally design immunization methodologies for 
nanoparticle-based delivery systems. These methodologies may reduce the required dose 
and enhance the breadth and depth of protective immune responses.  
In previous studies, experimental methods for the design and characterisation of 
nanoparticles directly from oil-in-water microemulsion precursors have been developed, 
and the breadth and depth of immune responses after immunisation with nanoparticles 
were enhanced34, 35.36. The intradermal administration of novel cationic nanoparticle-based 
DNA vaccine delivery systems using a jet injection device led to significantly enhanced 
Th1/Th2-balanced immune responses.  
To elicit effective mucosal and systemic immune responses, a novel cationic DNA-coated 
nanoparticle engineered from a microemulsion precursor was modified, optimised and 
applied intranasally as a vaccine delivery system. DNA-coated nanoparticles significantly 
enhanced specific serum IgG and IgA. An enhanced splenocyte proliferative response was 
also observed after immunisation with pDNA-coated nanoparticles; thus, these particles 
may be used for immunisation via the nasal route25 and inhalable nanoparticles may 
enhance immune responses25,28. 
6. Conclusion 
The exact mechanism of the modification of mucosal immune response by microemulsions 
remains to be elucidated. However, the effect of microemulsions may be attributed to an 
enhancement in nanoparticle uptake by cells present in the mucosal immune system. The 
incorporation of antigens into nanoparticles may be a promising approach because colloidal 
formulations protect antigens from degrading milieu in the mucosa and facilitate their 
transport across barriers.  
The use of nanoparticles for vaccine delivery provides beneficial effects, and good immune 
responses can be achieved. Although the mechanism of induction of mucosal immunity 
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after vaccination has not been fully elucidated, antigens associated with microemulsion 
nanoparticles may enhance mucosal immune responses and improve vaccination methods. 
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